← Back to Search

Intermittent Fasting Diet for Psoriasis and Psoriatic Arthritis

N/A

Recruiting

Led By Benjamin H Kaffenberger, MD, MS

Research Sponsored by Ohio State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age and older

Established patient at the clinical site with a diagnosis of mild to moderate plaque psoriasis despite treatment

Must not have

Obesity due to medical condition

Severe heart, kidney, and liver disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0 weeks (baseline), 12 weeks, 24 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is studying whether intermittent fasting can improve psoriasis & PsA disease severity & quality of life. It will look at clinical parameters, biometric measurements, & quality of life indices. Results will help determine the role of IMF & other diets in psoriasis & provide dietary recommendations.

Who is the study for?

This trial is for adults over 18 with mild to moderate plaque psoriasis, who are overweight and have been stable on their current psoriasis treatment for at least 6 weeks. It's not suitable for insulin-dependent diabetics, pregnant or breastfeeding individuals, those with severe organ disease, or anyone using medical weight loss treatments.

What is being tested?

The study tests if an Intermittent Fasting Diet (IMF) can improve the severity of psoriasis and Psoriatic Arthritis (PsA), as well as quality of life. Participants will either follow the IMF diet or their usual diet for 24 weeks. The effects will be monitored through regular check-ins and assessments by a physician.

What are the potential side effects?

While intermittent fasting is generally considered safe, potential side effects may include hunger, fatigue, headaches, irritability during fasting periods. Long-term adherence could potentially affect metabolism.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have mild to moderate plaque psoriasis and treatments haven't worked.

Select...

I haven't changed my psoriasis treatment in the last 6 weeks.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My obesity is caused by a medical condition.

Select...

I do not have severe heart, kidney, or liver disease.

Select...

I use insulin for my diabetes.

Select...

I am using medication to help with weight loss.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0 weeks (baseline), 12 weeks, 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0 weeks (baseline), 12 weeks, 24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 weeks (baseline), 12 weeks, 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Joints

Skin

Secondary study objectives

Skin

Body Mass Index (BMI)

Nail plate

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intermittent Fasting GroupExperimental Treatment1 Intervention

Patients in this group will do intermittent fasting dieting for 12 weeks, meaning they will only eat for 8 hours per day. They may choose whichever 8 hours they want. Only water can be consumed during the fasting period. For the last 12 weeks of the study, they will resume their normal diet.

Group II: Standard Routine Diet GroupActive Control1 Intervention

Patients will continue with their normal diets for the 24 week duration of the study.

0 / 7Eligibility criteria met